Concepedia

Jong Sung Koh

JS

Statistics

Publications

29

Citations

1.2K

H-Index

19

Active since

1992

Affiliations

LG Chem (South Korea)(Current)

Korea Research Institute of Chemical Technology

National Cancer Center

Seoul National University

Biogen (United States)

Jong Sung Koh is an author at LG Chem (South Korea) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1992–2019

29

Publications

29

Prognostic significance of c‐Met expression in glioblastomas

Doo‐Sik Kong, Sang‐Yong Song, Duk‐Hwan Kim et al. · Cancer · 2008 · 182 citations · Full text

, , +16

Design of a nonnatural deoxyribonucleoside for recognition of GC base pairs by oligonucleotide-directed triple helix formation

Jong Sung Koh, Peter B. Dervan · Journal of the American Chemical Society · 1992 · 128 citations

, , +16

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer

Jiyeon Yun, Min Hee Hong, Seok‐Young Kim et al. · Clinical Cancer Research · 2019 · 126 citations · Full text

, , +14

A novel class of highly potent, selective, and non-peptidic inhibitor of ras farnesyltransferase (FTase)

Hyun Il Lee, Jin‐Ho Lee, Sangkyun Lee et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 90 citations · Full text

, , +6

Solid phase synthesis of hydantoin library using a novel cyclization and traceless cleavage step

Sang Woong Kim, Sang Youl Ahn, Jong Sung Koh et al. · Tetrahedron Letters · 1997 · 79 citations

, , +12

1–5 of 29